PNGAF (The Precision Peptide Co) Current Accrued Expense: $0.03 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PNGAF The Precision Peptide Co Inc PNGAF
22 GF Score
Price $0.32
! 4 Warning Signs
View Full Analysis

What is The Precision Peptide Co Current Accrued Expense?

The Precision Peptide Co PNGAF -0.37% 22 Current Accrued Expense is $0.03 Mil as of Apr. 2026. GuruFocus rates PNGAF with a GF Score™ of 22/100. The stock has 4 warning signs investors should review.

The Precision Peptide Co's Current Accrued Expense for the quarter that ended in Apr. 2026 was $0.03 Mil.

The Precision Peptide Co's quarterly Current Accrued Expense declined from Oct. 2025 ($0.04 Mil) to Jan. 2026 ($0.03 Mil) but then stayed the same from Jan. 2026 ($0.03 Mil) to Apr. 2026 ($0.03 Mil).

The Precision Peptide Co's annual Current Accrued Expense increased from Oct. 2023 ($0.06 Mil) to Oct. 2024 ($0.09 Mil) but then declined from Oct. 2024 ($0.09 Mil) to Oct. 2025 ($0.04 Mil).

The Precision Peptide Co Current Accrued Expense Related Terms

The Precision Peptide Co Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for The Precision Peptide Co's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Precision Peptide Co Current Accrued Expense Chart

The Precision Peptide Co Annual Data
Trend Oct21 Oct22 Oct23 Oct24 Oct25
Current Accrued Expense
0.02 0.11 0.06 0.09 0.04

The Precision Peptide Co Quarterly Data
Jul21 Oct21 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.05 0.04 0.03 0.03
PNGAF
22GF Score
The Precision Peptide Co Inc PNGAF
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Precision Peptide Co Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $0.03 Mil mean?
The Precision Peptide Co (PNGAF) has a Current Accrued Expense of $0.03 Mil as of Apr. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on The Precision Peptide Co and its competitors.
Is The Precision Peptide Co's Current Accrued Expense too high?
The Precision Peptide Co's current Current Accrued Expense is $0.03 Mil. Overall, The Precision Peptide Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does The Precision Peptide Co's Current Accrued Expense compare to KHC and GIS?
The Precision Peptide Co's Current Accrued Expense of $0.03 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Consumer Packaged Goods company?
A good Current Accrued Expense depends on the Consumer Packaged Goods industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on The Precision Peptide Co and its competitors. The Precision Peptide Co's current Current Accrued Expense is $0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Precision Peptide Co stock overvalued right now?
The Precision Peptide Co (PNGAF) has a current Current Accrued Expense of $0.03 Mil. The current Current Accrued Expense is $0.03 Mil. The Precision Peptide Co's overall GF Score™ is 22/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For The Precision Peptide Co (PNGAF), the current Current Accrued Expense is $0.03 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Precision Peptide Co Business Description

Other Exchanges XU0:GermanyBPC:Canada
Address 130th Street, Suite 8035, Surrey, BC, CAN, V3W 0H7
The Precision Peptide Co Inc is a food manufacturer and distributor of nutritional supplements, functional snacks, natural foods, peptides, and natural personal care products. The company offers end-to-end services from formulation and ingredient sourcing to final packaging and fulfillment. The Company has two reportable operating segments: the manufacturing and distribution of food products in Canada and the sale and delivery of its peptide products in the United States.
22GF Score

Get the complete analysis for PNGAF

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.32
Price